| Pfizer AG - FSME-Immun CC, Injektionssuspension in einer Fertigspritze | | 00450 | | 02 | | FSME-Immun CC | | Injektionssuspension in einer Fertigspritze | | J07BA01 | | Encephalitis, Tick Borne, Inactivated, Whole Virus | | 05.11.2001 | | |
| | Composition | | virus FSME inactivatus (Stamm Neudörfl) 2.4 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.35 mg, albuminum seri humani, natrii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.42 mg et kalium 0.013 mg, residui: saccharum, formaldehydum, protamini sulfas, neomycinum, gentamicinum. | | Packungsbestandteile | | Suspension zur intramuskulären Injektion | | | | | | | | Active Agent | Dose |
|---|
| Virus fsme Inactivatus (Stamm Neudörfl.) | 2.4µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Virus fsme Inactivatum (Stamm Neudörfl.) | 2.4 mcg |
| | | | Inactive agents |
|---|
| Albuminum Seri Humani | | Aluminii Hydroxidum Hydricum ad Adsorptionem | | Disodium Phosphate Dihydrate | | Potassium Dihydrogenophosphate | | Sodium Chloride |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | Fertigspritze(n) | 27.00 | 45.80 | B | SL | Yes | | 004 | 10 Fertigspritze(n) | PR | PR | B | | Yes |
|
|
